Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Clinical Genomics Companies

Clinical genomics companies focus on leveraging genomic information for clinical applications, including diagnostic testing, personalized medicine, and disease risk assessment. These companies often use advanced sequencing technologies and bioinformatics to analyze genomic data for medical purposes.

Clinical Genomics Key Companies

Latest Clinical Genomics Companies Update:

Illumina Launched Connected Insights, a cloud-based software for tertiary analysis of clinical next-generation sequencing data, in March 2023.

Natera Received FDA approval for their Signatera™ MRD (minimal residual disease) test for bladder cancer in August 2023.

Myriad Genetics Partnered with the Dana-Farber Cancer Institute in December 2023 to develop and clinically validate new genetic tests for cancer risk assessment.

Invitae Corporation Announced the acquisition of Counsyl, Inc. in January 2024, strengthening their position in carrier screening and genetic testing services.

10x Genomics Developed the Visium Spatial Gene Expression platform for analyzing gene activity patterns within tissue samples, offering valuable insights into disease mechanisms.

List of Clinical Genomics Key companies in the market

Quest Diagnostics Incorporated (U.S.)

Eurofins Scientific SE (Luxembourg)

Illumina, Inc. (U.S.)

PerkinElmer, Inc. (U.S.)

NeoGenomics Inc. (U.S.)

Foundation Medicine, Inc. (U.S.)

Rosetta Genomics Ltd. (Israel)

Invitae Corporation (U.S.)

Myriad Genetics, Inc. (U.S.)

Natera, Inc. (U.S.)

Genomic Health, Inc. (U.S.)

OPKO Health, Inc. (U.S.)

Centogene AG (Germany)

Clinical Genomics Pty Ltd. (Australia)

23andMe, Inc. (U.S.)

Iverson Genetic Diagnostics, Inc. (U.S.)

Veritas Genetics (U.S.)

Gene by Gene, Ltd. (U.S.)

GenomeDx Biosciences, Inc. (Canada)

MedGenome (India)

Strand Life Sciences Pvt. Ltd. (India)

Beijing Genomics Institute (BGI) (China)

Retrogen, Inc. (U.S.)

Personalis, Inc. (U.S.)

PathGroup (U.S.)

Clinical Genomics Market Highlights:

Clinical Genomics Market Size

Clinical Genomics Market Trends

Clinical Genomics Market Analysis

Clinical Genomics Market Share

Clinical Genomics Market Highlights:

Clinical Genomics Market Trends

Clinical Genomics Market Analysis

Clinical Genomics Market Share

Clinical Genomics Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.